查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1651980

癌症/肿瘤分析的全球市场:市场规模·占有率·趋势，产业分析 (癌症类别·各技术·手法·各用途·各地区)，未来预测 (2025年～2034年)

Cancer or Tumor Profiling Market Size, Share, Trends, Industry Analysis Report: By Cancer Type, Technology, Technique, Application, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2个工作天内

价格

根据 Polaris Market Research 的一项新研究，全球癌症/肿瘤分析市场预计到 2034 年将达到 353.6 亿美元。该研究报告对当前市场动态提供了详细的见解，并对未来市场成长进行了分析。

癌症/肿瘤分析市场的扩张受到全球癌症发生率上升和个人化医疗需求成长的推动。关键推动因素包括基因组技术的进步，例如下一代定序（NGS）和液体活检，这些技术可以实现更早的检测、更好的诊断和更有针对性的治疗。癌症/肿瘤分析的市场机会存在于新兴市场，这些市场中医疗保健机会和认知度的提高推动着癌症分析技术的采用。

人工智慧（AI）融入数据分析以及对非侵入性诊断方法的日益关注等趋势正在塑造市场。由于人们更加重视透过个人化和更​​有效的治疗策略来改善患者的治疗效果，预计生物标记发现的持续创新和精准诊断的监管支持将推动市场持续扩张。

癌症/肿瘤分析市场：分析概述

由于乳癌发生率高且对个人化治疗和基因组分析的需求不断增长，乳癌占据癌症/肿瘤分析市场的最大占有率。然而，由于液体活检和先进的基因组分析在早期检测和针对性治疗的应用越来越多，因此预计肺癌领域将实现最高成长。

基于技术，次世代定序 (NGS) 领域占据市场主导地位，为肿瘤的基因特征提供全面的见解并推动精准肿瘤学的发展。聚合酶炼式反应（PCR）领域是成长最快的技术领域，得益于其成本效益以及在早期癌症检测液体活检中的应用。

根据方法论，基因组学领域在癌症/肿瘤分析市场收入占有率中处于领先地位，因为它能够提供有关突变、基因表现和肿瘤异质性的深入分子数据，这对于个人化医疗至关重要。表观遗传学领域因其在阐明驱动癌症进展和治疗反应的分子机制方面发挥的作用而正在经历最快的增长。

基于应用，个人化医疗领域占据市场主导地位。越来越多的肿瘤学家采用基于基因组和生物标记的检测来指导治疗决策并改善患者的治疗效果。随着用于早期检测和监测癌症进展的新的、更精确的生物标记不断被发现，生物标记发现领域正在迅速发展。

由于北美拥有先进的医疗基础设施以及对精准肿瘤学的浓厚兴趣，预计其将占据最大的市场占有率。由于医疗保健机会的增加、癌症发病率的上升以及癌症分析技术的日益普及，亚太地区成为成长最快的市场。

目录

第1章 简介

第2章 摘要整理

第3章 分析方法

第4章 癌症/肿瘤分析市场洞察

  • 市场概述
  • 癌症/肿瘤分析市场动态
    • 推动因素和机遇
      • 将液体切片融入诊断
      • 新一代定序 (NGS) 的作用不断扩大
    • 阻碍因素和课题
      • 分析技术成本高
  • 大环境分析
  • 全球癌症/肿瘤分析市场趋势
  • 价值链分析
  • COVID-19影响分析

第5章 全球癌症/肿瘤分析市场:癌症类别

  • 主要的分析结果
  • 简介
  • 乳癌
  • 肺癌症
  • 大肠癌症
  • 前列腺癌症
  • 黑色素瘤癌症
  • 其他

第6章 全球癌症/肿瘤分析市场:各技术

  • 主要的分析结果
  • 简介
  • 次世代定序 (NGS)
  • 聚合酵素链锁反应 (PCR)
  • 免疫组织化学 (IHC)
  • 界内犀牛亲嘴杂合反应 (ISH)
  • 微阵列
  • 其他

第7章 全球癌症/肿瘤分析市场:手法

  • 主要的分析结果
  • 简介
  • 基因学
  • 蛋白质体学
  • 表观遗传学
  • 代谢体学

第8章 全球癌症/肿瘤分析市场:各用途

  • 主要的分析结果
  • 简介
  • 个人化医疗
  • 诊断
  • 生物标誌物的发现
  • 预测
  • 其他

第9章 全球癌症/肿瘤分析市场:各地区

  • 主要的分析结果
  • 简介
    • 全球癌症/肿瘤分析市场评估:各地区 (2020～2034年)
  • 北美
    • 北美:癌症类别 (2020～2034年)
    • 北美:各技术 (2020～2034年)
    • 北美:手法 (2020～2034年)
    • 北美:各用途 (2020～2034年)
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:癌症类别 (2020～2034年)
    • 欧洲:各技术 (2020～2034年)
    • 欧洲:手法 (2020～2034年)
    • 欧洲:各用途 (2020～2034年)
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
    • 其他欧洲
  • 亚太地区
    • 亚太地区:癌症类别 (2020～2034年)
    • 亚太地区:各技术 (2020～2034年)
    • 亚太地区:手法 (2020～2034年)
    • 亚太地区:各用途 (2020～2034年)
    • 中国
    • 印度
    • 马来西亚
    • 日本
    • 印尼
    • 韩国
    • 澳洲
    • 其他亚太地区
  • 中东·非洲
    • 中东·非洲:癌症类别 (2020～2034年)
    • 中东·非洲:各技术 (2020～2034年)
    • 中东·非洲:手法 (2020～2034年)
    • 中东·非洲:各用途 (2020～2034年)
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
    • 其他中东·非洲
  • 南美
    • 南美:癌症类别 (2020～2034年)
    • 南美:各技术 (2020～2034年)
    • 南美:手法 (2020～2034年)
    • 南美:各用途 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美国家

第10章 竞争情形

  • 事业扩大·企业收购的分析
    • 事业扩大
    • 企业收购
  • 联盟/合作/协定/公开

第11章 企业简介

  • Illumina
  • Thermo Fisher Scientific
  • Qiagen
  • F. Hoffmann-La Roche
  • Agilent Technologies
  • Bio-Rad Laboratories
  • PerkinElmer
  • Foundation Medicine (a Roche subsidiary)
  • Guardant Health
  • NeoGenomics Laboratories
  • Pacific Biosciences
  • Personalis
  • GRAIL (a subsidiary of Illumina)
  • Invitae
  • Genomic Health (a subsidiary of Exact Sciences)
Product Code: PM1713

The global cancer or tumor profiling market size is expected to reach USD 35.36 billion by 2034, according to a new study by Polaris Market Research. The report "Cancer or Tumor Profiling Market Size, Share, Trends, Industry Analysis Report: By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Technology, Technique, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The cancer or tumor profiling market expansion is driven by the increasing prevalence of cancer worldwide and the growing demand for personalized medicine. Key drivers include advancements in genomic technologies such as next-generation sequencing (NGS) and liquid biopsy, which enable early detection, better diagnosis, and more targeted treatments. Cancer or tumor profiling market opportunities exist in emerging markets, where rising healthcare access and awareness are boosting the adoption of cancer profiling technologies.

Trends such as the integration of artificial intelligence (AI) for data analysis and the growing focus on noninvasive diagnostic techniques are shaping the market. With ongoing innovations in biomarker discovery and regulatory support for precision diagnostics, the market is poised for continued expansion, with a heightened emphasis on improving patient outcomes through personalized and more effective treatment strategies.

Cancer or Tumor Profiling Market Report Highlights

The breast cancer segment, by cancer type, holds the largest cancer or tumor profiling market share due to its high prevalence and the growing demand for personalized treatments and genomic profiling. However, the lung cancer segment is registering the highest growth due to the increasing use of liquid biopsy and advanced genomic profiling for early detection and targeted therapies.

By technology, the next-generation sequencing (NGS) segment dominates the market, offering comprehensive insights into tumor genetic profiles and driving precision oncology. The polymerase chain reaction (PCR) segment is the fastest-growing technology segment, fueled by its cost-effectiveness and application in liquid biopsy for early cancer detection.

The genomics segment, based on technique, leads the cancer or tumor profiling market revenue share due to its ability to provide in-depth molecular data on mutations, gene expressions, and tumor heterogeneity, which are critical for personalized medicine. The epigenetics segment is experiencing the highest growth, driven by its role in uncovering molecular mechanisms that drive cancer progression and response to treatment.

In terms of application, the personalized medicine segment dominates the market, as more oncologists adopt genomic and biomarker-based testing to guide treatment decisions and improve patient outcomes. The biomarker discovery segment is growing rapidly as new and more precise biomarkers are being identified for early detection and monitoring of cancer progression.

North America holds the largest market share, supported by its advanced healthcare infrastructure and strong focus on precision oncology. Asia Pacific is the fastest-growing market, driven by increasing healthcare access, rising cancer rates, and expanding adoption of cancer profiling technologies.

Polaris Market Research has segmented the cancer or tumor profiling market report on the basis of cancer type, technology, technique, application, and region:

By Cancer Type Outlook (Revenue - USD Billion, 2020-2034)

  • Breast Cancer
  • Lung Cancer
  • Colorectal Cancer
  • Prostate Cancer
  • Melanoma Cancer
  • Others

By Technology Outlook (Revenue - USD Billion, 2020-2034)

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Immunohistochemistry (IHC)
  • In-Situ Hybridization (ISH)
  • Microarray
  • Others

By Technique Outlook (Revenue - USD Billion, 2020-2034)

  • Genomics
  • Proteomics
  • Epigenetics
  • Metabolomics

By Application Outlook (Revenue - USD Billion, 2020-2034)

  • Personalized Medicine
  • Diagnostics
  • Biomarker Discovery
  • Prognostics
  • Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Netherlands
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Malaysia
  • South Korea
  • Indonesia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Middle East & Africa
  • Saudi Arabia
  • UAE
  • Israel
  • South Africa
  • Rest of Middle East & Africa
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Cancer or Tumour Profiling Market Insights

  • 4.1. Global Cancer or Tumour Profiling Market - Market Snapshot
  • 4.2. Global Cancer or Tumour Profiling Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Integration of Liquid Biopsy in Diagnostics
      • 4.2.1.2. Growing Role of Next-Generation Sequencing (NGS)
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Profiling Technologies
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Global Cancer or Tumour Profiling Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Cancer or Tumour Profiling Market, by Cancer Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • 5.3. Breast Cancer
    • 5.3.1. Global Cancer or Tumour Profiling Market, by Breast Cancer, by Region, 2020-2034 (USD Billion)
  • 5.4. Lung Cancer
    • 5.4.1. Global Cancer or Tumour Profiling Market, by Lung Cancer, by Region, 2020-2034 (USD Billion)
  • 5.5. Colorectal Cancer
    • 5.5.1. Global Cancer or Tumour Profiling Market, by Colorectal Cancer, by Region, 2020-2034 (USD Billion)
  • 5.6. Prostate Cancer
    • 5.6.1. Global Cancer or Tumour Profiling Market, by Prostate Cancer, by Region, 2020-2034 (USD Billion)
  • 5.7. Melanoma Cancer
    • 5.7.1. Global Cancer or Tumour Profiling Market, by Melanoma Cancer, by Region, 2020-2034 (USD Billion)
  • 5.8. Others
    • 5.8.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Cancer or Tumour Profiling Market, by Technology

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • 6.3. Next-Generation Sequencing (NGS)
    • 6.3.1. Global Cancer or Tumour Profiling Market, by Next-Generation Sequencing (NGS), by Region, 2020-2034 (USD Billion)
  • 6.4. Polymerase Chain Reaction (PCR)
    • 6.4.1. Global Cancer or Tumour Profiling Market, by Bakery & Confectionary, by Region, 2020-2034 (USD Billion)
  • 6.5. Immunohistochemistry (IHC)
    • 6.5.1. Global Cancer or Tumour Profiling Market, by Immunohistochemistry (IHC), by Region, 2020-2034 (USD Billion)
  • 6.6. In-Situ Hybridization (ISH)
    • 6.6.1. Global Cancer or Tumour Profiling Market, by In-Situ Hybridization (ISH), by Region, 2020-2034 (USD Billion)
  • 6.7. Microarray
    • 6.7.1. Global Cancer or Tumour Profiling Market, by Microarray, by Region, 2020-2034 (USD Billion)
  • 6.8. Others
    • 6.8.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Cancer or Tumour Profiling Market, by Technique

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • 7.3. Genomics
    • 7.3.1. Global Cancer or Tumour Profiling Market, by Genomics, by Region, 2020-2034 (USD Billion)
  • 7.4. Proteomics
    • 7.4.1. Global Cancer or Tumour Profiling Market, by Proteomics, by Region, 2020-2034 (USD Billion)
  • 7.5. Epigenetics
    • 7.5.1. Global Cancer or Tumour Profiling Market, by Epigenetics, by Region, 2020-2034 (USD Billion)
  • 7.6. Metabolomics
    • 7.6.1. Global Cancer or Tumour Profiling Market, by Metabolomics, by Region, 2020-2034 (USD Billion)

8. Global Cancer or Tumour Profiling Market, by Application

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 8.3. Personalized Medicine
    • 8.3.1. Global Cancer or Tumour Profiling Market, by Personalized Medicine, by Region, 2020-2034 (USD Billion)
  • 8.4. Diagnostics
    • 8.4.1. Global Cancer or Tumour Profiling Market, by Diagnostics, by Region, 2020-2034 (USD Billion)
  • 8.5. Biomarker Discovery
    • 8.5.1. Global Cancer or Tumour Profiling Market, by Biomarker Discovery, by Region, 2020-2034 (USD Billion)
  • 8.6. Prognostics
    • 8.6.1. Global Cancer or Tumour Profiling Market, by Prognostics, by Region, 2020-2034 (USD Billion)
  • 8.7. Others
    • 8.7.1. Global Cancer or Tumour Profiling Market, by Others, by Region, 2020-2034 (USD Billion)

9. Global Cancer or Tumour Profiling Market, by Geography

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Cancer or Tumour Profiling Market Assessment, By Geography, 2020-2034 (USD billion)
  • 9.3. Global Cancer or Tumour Profiling Market - North America
    • 9.3.1. North America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.3.2. North America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.3.3. North America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.3.4. North America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.3.5. Global Cancer or Tumour Profiling Market - US
      • 9.3.5.1. US: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.3.5.2. US: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.3.5.3. US: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.3.5.4. US: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.3.6. Global Cancer or Tumour Profiling Market - Canada
      • 9.3.6.1. Canada: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.3.6.2. Canada: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.3.6.3. Canada: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.3.6.4. Canada: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.4. Global Cancer or Tumour Profiling Market - Europe
    • 9.4.1. Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.4.2. Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.4.3. Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.4.4. Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.5. Global Cancer or Tumour Profiling Market - UK
      • 9.4.5.1. UK: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.5.2. UK: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.5.3. UK: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.5.4. UK: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.6. Global Cancer or Tumour Profiling Market - France
      • 9.4.6.1. France: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.6.2. France: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.6.3. France: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.6.4. France: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.7. Global Cancer or Tumour Profiling Market - Germany
      • 9.4.7.1. Germany: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.7.2. Germany: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.7.3. Germany: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.7.4. Germany: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.8. Global Cancer or Tumour Profiling Market - Italy
      • 9.4.8.1. Italy: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.8.2. Italy: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.8.3. Italy: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.8.4. Italy: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.9. Global Cancer or Tumour Profiling Market - Spain
      • 9.4.9.1. Spain: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.9.2. Spain: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.9.3. Spain: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.9.4. Spain: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.10. Global Cancer or Tumour Profiling Market - Netherlands
      • 9.4.10.1. Netherlands: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.10.2. Netherlands: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.10.3. Netherlands: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.10.4. Netherlands: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.11. Global Cancer or Tumour Profiling Market - Russia
      • 9.4.11.1. Russia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.11.2. Russia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.11.3. Russia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.11.4. Russia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.4.12. Global Cancer or Tumour Profiling Market - Rest of Europe
      • 9.4.12.1. Rest of Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.4.12.2. Rest of Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.4.12.3. Rest of Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.4.12.4. Rest of Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.5. Global Cancer or Tumour Profiling Market - Asia Pacific
    • 9.5.1. Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.5.2. Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.5.3. Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.5.4. Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.5. Global Cancer or Tumour Profiling Market - China
      • 9.5.5.1. China: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.5.2. China: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.5.3. China: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.5.4. China: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.6. Global Cancer or Tumour Profiling Market - India
      • 9.5.6.1. India: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.6.2. India: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.6.3. India: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.6.4. India: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.7. Global Cancer or Tumour Profiling Market - Malaysia
      • 9.5.7.1. Malaysia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.7.2. Malaysia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.7.3. Malaysia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.7.4. Malaysia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.8. Global Cancer or Tumour Profiling Market - Japan
      • 9.5.8.1. Japan: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.8.2. Japan: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.8.3. Japan: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.8.4. Japan: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.9. Global Cancer or Tumour Profiling Market - Indonesia
      • 9.5.9.1. Indonesia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.9.2. Indonesia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.9.3. Indonesia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.9.4. Indonesia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.10. Global Cancer or Tumour Profiling Market - South Korea
      • 9.5.10.1. South Korea: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.10.2. South Korea: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.10.3. South Korea: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.10.4. South Korea: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.11. Global Cancer or Tumour Profiling Market - Australia
      • 9.5.11.1. Australia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.11.2. Australia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.11.3. Australia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.11.4. Australia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.5.12. Global Cancer or Tumour Profiling Market - Rest of Asia Pacific
      • 9.5.12.1. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.5.12.2. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.5.12.3. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.5.12.4. Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.6. Global Cancer or Tumour Profiling Market - Middle East & Africa
    • 9.6.1. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.6.2. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.6.3. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.6.4. Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.6.5. Global Cancer or Tumour Profiling Market - Saudi Arabia
      • 9.6.5.1. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.6.5.2. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.6.5.3. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.6.5.4. Saudi Arabia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.6.6. Global Cancer or Tumour Profiling Market - UAE
      • 9.6.6.1. UAE: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.6.6.2. UAE: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.6.6.3. UAE: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.6.6.4. UAE: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.6.7. Global Cancer or Tumour Profiling Market - Israel
      • 9.6.7.1. Israel: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.6.7.2. Israel: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.6.7.3. Israel: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.6.7.4. Israel: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.6.8. Global Cancer or Tumour Profiling Market - South Africa
      • 9.6.8.1. South Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.6.8.2. South Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.6.8.3. South Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.6.8.4. South Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.6.9. Global Cancer or Tumour Profiling Market - Rest of Middle East & Africa
      • 9.6.9.1. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.6.9.2. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.6.9.3. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.6.9.4. Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • 9.7. Global Cancer or Tumour Profiling Market - Latin America
    • 9.7.1. Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
    • 9.7.2. Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
    • 9.7.3. Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
    • 9.7.4. Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.7.5. Global Cancer or Tumour Profiling Market - Mexico
      • 9.7.5.1. Mexico: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.7.5.2. Mexico: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.7.5.3. Mexico: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.7.5.4. Mexico: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.7.6. Global Cancer or Tumour Profiling Market - Brazil
      • 9.7.6.1. Brazil: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.7.6.2. Brazil: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.7.6.3. Brazil: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.7.6.4. Brazil: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.7.7. Global Cancer or Tumour Profiling Market - Argentina
      • 9.7.7.1. Argentina: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.7.7.2. Argentina: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.7.7.3. Argentina: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.7.7.4. Argentina: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
    • 9.7.8. Global Cancer or Tumour Profiling Market - Rest of Latin America
      • 9.7.8.1. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
      • 9.7.8.2. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
      • 9.7.8.3. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
      • 9.7.8.4. Rest of Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)

10. Competitive Landscape

  • 10.1. Expansion and Acquisition Analysis
    • 10.1.1. Expansion
    • 10.1.2. Acquisitions
  • 10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

  • 11.1. Illumina
    • 11.1.1. Company Overview
    • 11.1.2. Financial Performance
    • 11.1.3. Product Benchmarking
    • 11.1.4. Recent Development
  • 11.2. Thermo Fisher Scientific
    • 11.2.1. Company Overview
    • 11.2.2. Financial Performance
    • 11.2.3. Product Benchmarking
    • 11.2.4. Recent Development
  • 11.3. Qiagen
    • 11.3.1. Company Overview
    • 11.3.2. Financial Performance
    • 11.3.3. Product Benchmarking
    • 11.3.4. Recent Development
  • 11.4. F. Hoffmann-La Roche
    • 11.4.1. Company Overview
    • 11.4.2. Financial Performance
    • 11.4.3. Product Benchmarking
    • 11.4.4. Recent Development
  • 11.5. Agilent Technologies
    • 11.5.1. Company Overview
    • 11.5.2. Financial Performance
    • 11.5.3. Product Benchmarking
    • 11.5.4. Recent Development
  • 11.6. Bio-Rad Laboratories
    • 11.6.1. Company Overview
    • 11.6.2. Financial Performance
    • 11.6.3. Product Benchmarking
    • 11.6.4. Recent Development
  • 11.7. PerkinElmer
    • 11.7.1. Company Overview
    • 11.7.2. Financial Performance
    • 11.7.3. Product Benchmarking
    • 11.7.4. Recent Development
  • 11.8. Foundation Medicine (a Roche subsidiary)
    • 11.8.1. Company Overview
    • 11.8.2. Financial Performance
    • 11.8.3. Product Benchmarking
    • 11.8.4. Recent Development
  • 11.9. Guardant Health
    • 11.9.1. Company Overview
    • 11.9.2. Financial Performance
    • 11.9.3. Product Benchmarking
    • 11.9.4. Recent Development
  • 11.10. NeoGenomics Laboratories
    • 11.10.1. Company Overview
    • 11.10.2. Financial Performance
    • 11.10.3. Product Benchmarking
    • 11.10.4. Recent Development
  • 11.11. Pacific Biosciences
    • 11.11.1. Company Overview
    • 11.11.2. Financial Performance
    • 11.11.3. Product Benchmarking
    • 11.11.4. Recent Development
  • 11.12. Personalis
    • 11.12.1. Company Overview
    • 11.12.2. Financial Performance
    • 11.12.3. Product Benchmarking
    • 11.12.4. Recent Development
  • 11.13. GRAIL (a subsidiary of Illumina)
    • 11.13.1. Company Overview
    • 11.13.2. Financial Performance
    • 11.13.3. Product Benchmarking
    • 11.13.4. Recent Development
  • 11.14. Invitae
    • 11.14.1. Company Overview
    • 11.14.2. Financial Performance
    • 11.14.3. Product Benchmarking
    • 11.14.4. Recent Development
  • 11.15. Genomic Health (a subsidiary of Exact Sciences)
    • 11.15.1. Company Overview
    • 11.15.2. Financial Performance
    • 11.15.3. Product Benchmarking
    • 11.15.4. Recent Development

List of Tables:

  • Table 1 Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 2 Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 3 Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 4 Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 5 North America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 6 North America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 7 North America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 8 North America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 9 US: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 10 US: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 11 US: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 12 US: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 13 Canada: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 14 Canada: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 15 Canada: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 16 Canada: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 17 Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 18 Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 19 Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 20 Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 21 UK: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 22 UK: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 23 UK: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 24 UK: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 25 France: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 26 France: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 27 France: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 28 France: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 29 Germany: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 30 Germany: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 31 Germany: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 32 Germany: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 33 Italy: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 34 Italy: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 35 Italy: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 36 Italy: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 37 Spain: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 38 Spain: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 39 Spain: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 40 Spain: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 41 Netherlands: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 42 Netherlands: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 43 Netherlands: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 44 Netherlands: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 45 Russia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 46 Russia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 47 Russia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 48 Russia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 49 Rest of Europe: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 50 Rest of Europe: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 51 Rest of Europe: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 52 Rest of Europe: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 53 Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 54 Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 55 Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 56 Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 57 China: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 58 China: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 59 China: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 60 China: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 61 India: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 62 India: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 63 India: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 64 India: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 65 Malaysia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 66 Malaysia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 67 Malaysia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 68 Malaysia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 69 Japan: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 70 Japan: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 71 Japan: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 72 Japan: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 73 Indonesia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 74 Indonesia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 75 Indonesia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 76 Indonesia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 77 South Korea: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 78 South Korea: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 79 South Korea: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 80 South Korea: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 81 Australia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 82 Australia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 83 Australia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 84 Australia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 85 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 86 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 87 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 88 Rest of Asia Pacific: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 89 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 90 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 91 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 92 Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 93 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 94 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 95 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 96 Saudi Arabia: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 97 UAE: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 98 UAE: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 99 UAE: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 100 UAE: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 101 Israel: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 102 Israel: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 103 Israel: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 104 Israel: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 105 South Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 106 South Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 107 South Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 108 South Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 109 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 110 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 111 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 112 Rest of Middle East & Africa: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 113 Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 114 Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 115 Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 116 Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 117 Mexico: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 118 Mexico: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 119 Mexico: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 120 Mexico: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 121 Brazil: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 122 Brazil: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 123 Brazil: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 124 Brazil: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 125 Argentina: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 126 Argentina: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 127 Argentina: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 128 Argentina: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)
  • Table 129 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Cancer Type, 2020-2034 (USD billion)
  • Table 130 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technology, 2020-2034 (USD billion)
  • Table 131 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Technique, 2020-2034 (USD billion)
  • Table 132 Rest of Latin America: Global Cancer or Tumour Profiling Market, by Application, 2020-2034 (USD billion)

List of Figures:

  • Figure 1. Global Cancer or Tumour Profiling Market, 2020-2034 (USD billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Cancer Type
  • Figure 7. Global Cancer or Tumour Profiling Market, by Cancer Type, 2024 & 2034 (USD billion)
  • Figure 8. Market by Technology
  • Figure 9. Global Cancer or Tumour Profiling Market, by Technology, 2024 & 2034 (USD billion)
  • Figure 10. Market by Technique
  • Figure 11. Global Cancer or Tumour Profiling Market, by Technique, 2024 & 2034 (USD billion)
  • Figure 12. Market by Application
  • Figure 13. Global Cancer or Tumour Profiling Market, by Application, 2024 & 2034 (USD billion)
  • Figure 14. Global Cancer or Tumour Profiling Market Assessment, By Geography, 2020-2034 (USD billion)
  • Figure 15. Strategic Analysis - Global Cancer or Tumour Profiling Market